Related Experiment Video
Updated: Feb 9, 2026

Fabrication of White Light-emitting Electrochemical Cells with Stable Emission from Exciplexes
Published on: November 15, 2016
Tb3+, Eu3+ Co-doped CsPbBr3 QDs Glass with Highly Stable and Luminous Adjustable for White LEDs
Yinzi Cheng1, Chenyang Shen1, Linli Shen1
1College of Chemistry and Materials Engineering, College of Life and Environmental Science , Wenzhou University , Wenzhou 325035 , People's Republic of China.
Abstract:
Herein, we have introduced rare-earth cations Tb3+ and Eu3+ into CsPbBr3 QDs glass by conventional melt-quenching. Rare-earth cations like Tb3+ emit green light, causing the main peak of bromide lead cesium to exhibit some redshift, owing to the energy transfer between CsPbBr3 and Tb3+. To achieve adjustable light, Eu3+ emits red light, which was doped in this glass with different proportions to solve the problem of red deficiency. More importantly, Tb3+ and Eu3+ co-doped CsPbBr3 QDs glass shows a series of desirable characteristics due to the energy transfer between Tb3+ and Eu3+. Interestingly, the blue light radiated by blue chip can excite Tb3+, Eu3+, and CsPbBr3 perovskite effectively. We acquired high-performance white light-emitting diodes with color-rendering index, color coordinate transformation, and luminous efficiency of 85.7, 4945 K, and 63.21 lm/W under the current of 20 mA. This acquired Tb3+, Eu3+ co-doped CsPbBr3 QDs glass proved the significant feasibility of luminescent materials in solid warm light source.
Related Concept Videos
The Anchoring-and-Adjustment Heuristic
The Looking Glass Self
Adjusting a Traverse
Renal Failure: Dose Adjustments
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

